Startseite UR

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial

Zeyen, Thomas ; Potthoff, Anna-Laura ; Nemeth, Robert ; Heiland, Dieter H. ; Burger, Michael C. ; Steinbach, Joachim P. ; Hau, Peter ; Tabatabai, Ghazaleh ; Glas, Martin ; Schlegel, Uwe ; Grauer, Oliver ; Krex, Dietmar ; Schnell, Oliver ; Goldbrunner, Roland ; Sabel, Michael ; Thon, Niklas ; Delev, Daniel ; Clusmann, Hans ; Seidel, Clemens ; Güresir, Erdem ; Schmid, Matthias ; Schuss, Patrick ; Giordano, Frank A. ; Radbruch, Alexander ; Becker, Albert ; Weller, Johannes ; Schaub, Christina ; Vatter, Hartmut ; Schilling, Judith ; Winkler, Frank ; Herrlinger, Ulrich ; Schneider, Matthias



Zusammenfassung

Background: Glioblastoma is the most frequent and malignant primary brain tumor. Even in the subgroup with O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and favorable response to first-line therapy, survival after relapse is short (12 months). Standard therapy for recurrent MGMT-methylated glioblastoma is not standardized and may consist of re-resection, re-irradiation, and ...

plus


Nur für Besitzer und Autoren: Kontrollseite des Eintrags
  1. Universität

Universitätsbibliothek

Publikationsserver

Kontakt:

Publizieren: oa@ur.de
0941 943 -4239 oder -69394

Dissertationen: dissertationen@ur.de
0941 943 -3904

Forschungsdaten: datahub@ur.de
0941 943 -5707

Ansprechpartner